Navigation Links
New Psoriasis Drugs Not Much Better Than Standard Therapy, Study Finds
Date:4/19/2012

By Ellin Holohan
HealthDay Reporter

THURSDAY, April 19 (HealthDay News) -- Newer, more expensive medications don't work much better for the chronic inflammatory skin disease known as psoriasis than the standard treatment, a new study indicates.

The researchers found that biologics, which can cost upwards of $10,000 a year, were slightly more effective than a standard drug treatment for psoriasis, methotrexate, but that their impact lessened over time.

The findings provide only limited hope for psoriasis sufferers, who sometimes stop traditional treatments because of nausea and other bad reactions.

"When one looks at the outcome as being clear, or almost clear [skin], the biologics appear to be more effective than methotrexate," said study author Dr. Joel Gelfand. But, when total body surface area affected by the disease is added in that difference diminishes, he said.

The study, published in the April issue of the Archives of Dermatology, was conducted from February 2010 through June 2011 in clinics at the University of Pennsylvania and University of Utah, as well as six private practices around the country. It was designed to look at treatment "in real-world conditions," as opposed to clinical trials, which have showed better results in the past, the study said.

Psoriasis, an autoimmune system disease, causes itchy, scaly, red patches of skin, mostly on the elbows, knees and torso. Moderate to severe rashes afflict about 25 million people worldwide, including 1.4 million people in the United States.

The condition usually emerges in early adulthood, and is associated with elevated risks of cardiovascular disease and early death, according to research cited in the study.

Genetics play an "important role" in who gets psoriasis, said Gelfand, who is also an assistant professor of dermatology and epidemiology at the University of Pennsylvania, noting that environmental factors such
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2 3

Related medicine news :

1. Psoriasis Patients May Face Higher Heart Risk
2. Smoking Linked to Higher Rate of Psoriasis: Study
3. New Guidelines for Treating Psoriasis When Pregnant or Nursing
4. Psoriasis Treatments Convenience May Be Key for Patients
5. Does Psoriasis Thwart the Benefits of Good Cholesterol?
6. Psoriasis is associated with impaired HDL function, Penn study finds
7. Experimental Psoriasis Drug Bests Older Treatment
8. 1 in 4 With Psoriasis May Have Undiagnosed Arthritis
9. Kids With Psoriasis Get Inconsistent Care
10. Injectable Psoriasis Drugs May Not Hike Heart Risks: Study
11. Scientists Close in on Origins of Psoriasis, Eczema
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Psoriasis Drugs Not Much Better Than Standard Therapy, Study Finds
(Date:5/23/2013)... A medical malpractice case which was filed ... by Lori Mandel, an office manager in her 50’s, ... Ms. Mandel sought the medical expertise of an ... that affected the quality of her life and her ... that her doctor rendered conservative treatment for 2 years, ...
(Date:5/23/2013)... can cause rapidly progressing, life threatening meningitis and meningococcal ... have not known how it attaches to the human ... attaches to the airway to colonise", People can be ... while some people progress to invasive disease. To ... how the bacterium colonises the airway. Now that the ...
(Date:5/23/2013)... , , WEDNESDAY, May 22 (HealthDay News) -- The success of ... born with a serious airway malformation sheds light on new ... A report in the May 23 New England Journal ... At first, the baby born five weeks early seemed ... eating when he was 6 weeks old. Just two weeks ...
(Date:5/23/2013)... DRE, Inc. is now offering the DRE ... upgrade older model DRE or BFW halogen headlights to ... , DRE and BFW customers can easily and affordably ... to LED with DRE’s American-made Xavier-C3 LED headlight conversion ... a bright, clean and even field of illumination with ...
(Date:5/23/2013)... May 23, 2013 In Florida, residents have ... This doesn’t mean, however, that Florida’s good luck will continue, ... . This year, he encourages residents, it is important to ... 2013, forecasters are predicting there to be a 50-percent chance ... . With hurricane season lasting from June 1 to November ...
Breaking Medicine News(10 mins):Health News:New York Law Journal Releases Top Medical Malpractice Case for 2012: NY Supreme Court Awards $8.6 Million to Plaintiff after Doctor's Misdiagnosis Led to Personal Injury 2Health News:New York Law Journal Releases Top Medical Malpractice Case for 2012: NY Supreme Court Awards $8.6 Million to Plaintiff after Doctor's Misdiagnosis Led to Personal Injury 3Health News:New discovery in fight against deadly meningococcal disease 2Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 2Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 3Health News:New DRE, Inc. LED Conversion Kit Allows Doctors to Upgrade Older Halogen Technology Without Replacing Entire Lighting Systems 2Health News:New DRE, Inc. LED Conversion Kit Allows Doctors to Upgrade Older Halogen Technology Without Replacing Entire Lighting Systems 3Health News:As Hurricane Season Nears, Skylake Insurance Encourages Florida Residents To Prepare Early For Safety 2
... There,s little benefit to parents or baby in learning before ... new study suggests. Researchers led by Dr. James Robbins, ... 235 mothers of children aged 2 to 7 years with ... condition was identified before birth (prenatally) in 46 percent of ...
... , FRIDAY, Nov. 26 (HealthDay News) -- Most American ... the topic is far less likely to arise in homes without ... half of American households have a gun, and nearly 30 children ... owned by the child,s family or friends, according to researchers at ...
... HealthDay Reporter , WEDNESDAY, Nov. 24 (HealthDay News) ... and want to keep the weight off, a new Danish ... refined carbohydrates. Based on the findings, the researchers advise ... whole-grain breads. The glycemic index (GI) is a measure of ...
... devastating cholera outbreaks in refugee camps in earthquake-wracked Haiti, ... George Washington University, and the International Vaccine Institute (IVI) ... stockpile of cholera vaccines for future humanitarian use. ... maintaining a stockpile of several million doses of cholera ...
... Amanda Gardner HealthDay Reporter , WEDNESDAY, Nov. 24 ... blood cancers with bone marrow and blood stem cell transplants ... and death, a new study shows. Between the early ... the overall risk of death in an analysis of more ...
... year has brought to light both the promise and ... the most deadly form of skin cancer. Early clinical ... cancer-causing gene revealed impressive results in patients whose cancers ... short-lived, as the tumors invariably returned a few months ...
Cached Medicine News:Health News: Gun-Safety Talk a Safe Bet for All Families, Experts Say 2Health News:More Protein, Fewer Refined Carbs May Keep Weight Off 2Health News:More Protein, Fewer Refined Carbs May Keep Weight Off 3Health News:Experts urge US to create emergency cholera vaccine stockpile for humanitarian use 2Health News:Experts urge US to create emergency cholera vaccine stockpile for humanitarian use 3Health News:Experts urge US to create emergency cholera vaccine stockpile for humanitarian use 4Health News:Study Finds Big Strides Made in Treating Leukemia, Lymphoma in Past Decade 2Health News:Study Finds Big Strides Made in Treating Leukemia, Lymphoma in Past Decade 3Health News:Study Finds Big Strides Made in Treating Leukemia, Lymphoma in Past Decade 4Health News:Researchers shine light on how some melanoma tumors evade drug treatment 2Health News:Researchers shine light on how some melanoma tumors evade drug treatment 3
(Date:5/23/2013)... 2013 Halozyme Therapeutics, Inc. (NASDAQ: ... David A. Ramsay as ... Vice President, Corporate Development at Halozyme. ... his established financial management experience and his recent ... our commercial group for the last four years, ...
(Date:5/23/2013)... SAN DIEGO , May 23, 2013  MedVantx, ... to consumer pharmaceutical distribution channel announced today the Company ... platform to manage $1.5B in pharmaceutical products and the ... quality akin to cGMP facilities in its specialty home ... . The Company provides leading pharmaceutical manufacturers, physicians, health ...
(Date:5/23/2013)... , May 23, 2013   BioLife Solutions ... of proprietary clinical grade hypothermic storage and ... and contract aseptic media manufacturer , today announced ... & Regenerative Medicine Congress 2013 this week in ... http://photos.prnewswire.com/prnh/20090814/BIOLIFELOGO ) Dr. Aby J. Mathew, BioLife,s ...
Breaking Medicine Technology:Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer 2MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 2MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 3BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 2BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 3
... , RALEIGH, N.C., Dec. 9 ... Head of Infectious Diseases Carl Kraus, M.D., Vice President ... with John Powers, M.D., Assistant Professor of Medicine ... considerations in anti-infective drug development. , Understanding the current ...
... SAN DIEGO, Dec. 9 Sangart, Inc., a global ... to enhance the perfusion and oxygenation of ischemic (oxygen ... initiation of a dose-finding study designed to evaluate the ... care in severely injured trauma patients with lactic acidosis ...
Cached Medicine Technology:PRA International Hosts an Infectious Diseases Audio Conference 2PRA International Hosts an Infectious Diseases Audio Conference 3Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 2Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock 3
Used to introduce balloon, closed and non-tapered end catheters or other devices for intervention....
Used to introduce balloon, electrode, closed or non-tapered end catheters and other devices for intervention....
Used to introduce large balloon, closed and non-tapered end catheters or other devices for intervention....
Used to introduce large devices for vascular intervention....
Medicine Products: